- Home
- CDNA vs KRNT Comparison
CDNA vs KRNT Comparison
Compare CDNA & KRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- KRNT
- Stock Information
- Founded
- CDNA 1998
- KRNT 2002
- Country
- CDNA United States
- KRNT Israel
- Employees
- CDNA N/A
- KRNT N/A
- Industry
- CDNA Medical Specialities
- KRNT Industrial Machinery/Components
- Sector
- CDNA Health Care
- KRNT Industrials
- Exchange
- CDNA Nasdaq
- KRNT Nasdaq
- Market Cap
- CDNA 1.0B
- KRNT 923.5M
- IPO Year
- CDNA 2014
- KRNT 2015
- Fundamental
- Price
- CDNA $12.92
- KRNT $21.27
- Analyst Decision
- CDNA Buy
- KRNT Strong Buy
- Analyst Count
- CDNA 6
- KRNT 5
- Target Price
- CDNA $29.33
- KRNT $33.20
- AVG Volume (30 Days)
- CDNA 2.1M
- KRNT 172.8K
- Earning Date
- CDNA 07-30-2025
- KRNT 08-06-2025
- Dividend Yield
- CDNA N/A
- KRNT N/A
- EPS Growth
- CDNA N/A
- KRNT N/A
- EPS
- CDNA 1.07
- KRNT N/A
- Revenue
- CDNA $346,421,000.00
- KRNT $206,506,000.00
- Revenue This Year
- CDNA $13.31
- KRNT $10.86
- Revenue Next Year
- CDNA $15.46
- KRNT $12.68
- P/E Ratio
- CDNA $12.11
- KRNT N/A
- Revenue Growth
- CDNA 25.92
- KRNT N/A
- 52 Week Low
- CDNA $10.96
- KRNT $13.59
- 52 Week High
- CDNA $34.84
- KRNT $34.29
- Technical
- Relative Strength Index (RSI)
- CDNA 28.64
- KRNT 56.33
- Support Level
- CDNA $11.62
- KRNT $21.11
- Resistance Level
- CDNA $13.15
- KRNT $21.98
- Average True Range (ATR)
- CDNA 1.36
- KRNT 0.65
- MACD
- CDNA -0.91
- KRNT 0.22
- Stochastic Oscillator
- CDNA 18.04
- KRNT 71.67
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About KRNT Kornit Digital Ltd.
Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.